Tech Company Financing Transactions
Prellis Biologics Funding Round
On 9/14/2017, Prellis Biologics raised $1.9 million in funding from True Ventures, 415 Ventures and Civilization Ventures.
Transaction Overview
Company Name
Announced On
9/14/2017
Transaction Type
Venture Equity
Amount
$1,920,000
Round
Undisclosed
Investors
Proceeds Purpose
Prellis Bio will use the funding to create human tissue and organs with 3D printing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
900 Indiana St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Prellis Biologics, we are driven by our vision of a world where functional human tissues can be created on demand in a laboratory setting.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Melanie Matheu
Controller
Matthew Niemiec
VP - Bus. Development
Diana Bogorodskaya
VP - Engineering
Erik Busby
Browse more venture capital transactions:
Prev: 9/14/2017: Apttus venture capital transaction
Next: 9/14/2017: Snag-A-Slip venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs